Chemoinformaics analysis of (4S,5S,6R)-6-METHYLOXANE-2,4,5-TRIOL
| Molecular Weight | 148.158 | nRot | 0 |
| Heavy Atom Molecular Weight | 136.062 | nRig | 6 |
| Exact Molecular Weight | 148.074 | nRing | 1 |
| Solubility: LogS | 0.314 | nHRing | 1 |
| Solubility: LogP | -1.372 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 21.2295 |
| nHD | 3 | BPOL | 13.7745 |
| QED | 0.405 |
| Synth | 3.924 |
| Natural Product Likeliness | 2.831 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.086 |
| HIA | 0.303 |
| CACO-2 | -5.175 |
| MDCK | 0.000758777 |
| BBB | 0.366 |
| PPB | 0.0803235 |
| VDSS | 1.477 |
| FU | 0.842416 |
| CYP1A2-inh | 0.01 |
| CYP1A2-sub | 0.171 |
| CYP2c19-inh | 0.017 |
| CYP2c19-sub | 0.76 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.295 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.222 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.073 |
| CL | 5.867 |
| T12 | 0.727 |
| hERG | 0.018 |
| Ames | 0.434 |
| ROA | 0.173 |
| SkinSen | 0.208 |
| Carcinogencity | 0.034 |
| EI | 0.173 |
| Respiratory | 0.066 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.964275 |